去除T细胞的非清髓性干细胞移植：宿主预处理强度与移植物T细胞去除程度之间的最佳平衡是什么？ - Suppr | 超能文献

T cell-depleted nonmyeloablative stem cell transplantation: what is the optimum balance between the intensity of host conditioning and the degree of T cell depletion of the graft?

作者信息

Chakrabarti S, McDonald D, Milligan D W

出版信息

Bone Marrow Transplant. 2001 Aug;28(3):313-4. doi: 10.1038/sj.bmt.1703117.

DOI:10.1038/sj.bmt.1703117

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

T cell-depleted nonmyeloablative stem cell transplantation: what is the optimum balance between the intensity of host conditioning and the degree of T cell depletion of the graft?去除T细胞的非清髓性干细胞移植：宿主预处理强度与移植物T细胞去除程度之间的最佳平衡是什么？

Bone Marrow Transplant. 2001 Aug;28(3):313-4. doi: 10.1038/sj.bmt.1703117.

2

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.复发难治性霍奇金淋巴瘤异基因造血干细胞移植的减低剂量预处理：阿仑单抗和供体淋巴细胞输注对长期结局的影响

Br J Haematol. 2007 Oct;139(1):70-80. doi: 10.1111/j.1365-2141.2007.06759.x.

3

Polyoma viruria following T-cell-depleted allogeneic transplants using Campath-1H: incidence and outcome in relation to graft manipulation, donor type and conditioning.使用Campath-1H进行T细胞去除的同种异体移植后的多瘤病毒尿症：与移植物操作、供体类型和预处理相关的发病率及结局

Bone Marrow Transplant. 2003 Mar;31(5):379-86. doi: 10.1038/sj.bmt.1703847.

4

A comparison of Campath and Thymoglobulin as part of the conditioning before allogeneic hematopoietic stem cell transplantation.比较 Campath 和 Thymoglobulin 在异基因造血干细胞移植前预处理中的作用。

Eur J Haematol. 2011 Jan;86(1):57-66. doi: 10.1111/j.1600-0609.2010.01537.x. Epub 2010 Nov 25.

5

The role of alemtuzumab in nonmyeloablative hematopoietic transplantation.阿仑单抗在非清髓性造血移植中的作用。

Semin Oncol. 2006 Apr;33(2 Suppl 5):S36-43. doi: 10.1053/j.seminoncol.2006.01.028.

6

Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML.对于接受减低剂量预处理的成年急性髓系白血病同胞异基因造血干细胞移植患者，阿仑单抗可显著降低慢性移植物抗宿主病的发生率，且不影响总生存率。

Bone Marrow Transplant. 2009 May;43(9):709-15. doi: 10.1038/bmt.2008.375. Epub 2008 Nov 24.

7

Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning.在降低强度预处理后进行体外T细胞去除的异基因干细胞移植后，采用供体淋巴细胞输注治疗晚期慢性淋巴细胞白血病患者的移植物抗白血病反应的特征分析

Leukemia. 2007 Dec;21(12):2569-74. doi: 10.1038/sj.leu.2404838. Epub 2007 Jul 5.

8

Similar lymphocyte recovery and CMV reactivation profiles between reduced intensity conditioning with alemtuzumab and myeloablative allogeneic stem cell transplantation.使用阿仑单抗进行的减低剂量预处理与清髓性异基因干细胞移植之间，淋巴细胞恢复和巨细胞病毒再激活情况相似。

Bone Marrow Transplant. 2008 Apr;41(8):749-51. doi: 10.1038/sj.bmt.1705974. Epub 2008 Jan 14.

9

Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation.外周血干细胞中T细胞过度耗竭对异基因干细胞移植后的结果有不利影响。

Bone Marrow Transplant. 2001 Nov;28(9):827-34. doi: 10.1038/sj.bmt.1703248.

10

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?在非清髓性预处理时代，阿仑单抗（Campath-1H）用于治疗淋巴系统恶性肿瘤？

Bone Marrow Transplant. 2002 Dec;30(12):797-804. doi: 10.1038/sj.bmt.1703733.